Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket

Journal of Virology
Yang SuYuxian He

Abstract

The deep hydrophobic pocket on the N trimer of HIV-1 gp41 has been considered an ideal drug target. On the basis of the M-T hook structure, we recently developed short-peptide-based HIV-1 fusion inhibitors (MTSC22 and HP23), which mainly target the pocket site and possess highly potent antiviral activity. In this study, we focused on investigating their resistance pathways and mechanisms by escape HIV-1 mutants to SC22EK, a template peptide for MTSC22 and HP23. Two substitutions, E49K and N126K, located, respectively, at the N- and C-heptad repeat regions of gp41, were identified as conferring high resistance to the inhibitors targeting the pocket and cross-resistance to enfuvirtide (T20) and sifuvirtide (SFT). The underlying mechanisms of SC22EK-induced resistance include the following: (i) significantly reduced binding affinity of the inhibitors, (ii) dramatically enhanced interaction of the viral six-helix bundle, and (iii)severely damaged functionality of the viral Env complex. Our data have provided important information for the structure-function relationship of gp41 and the structure-activity relationship of viral fusion inhibitors. Enfuvirtide (T20) is the only HIV-1 fusion inhibitor in clinical use, but the problem of ...Continue Reading

References

Nov 1, 1989·Analytical Biochemistry·S C Gill, P H von Hippel
May 22, 1997·Nature·W WeissenhornD C Wiley
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·K TanM Lu
Jun 18, 1998·Cell·D C Chan, P S Kim
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·D C ChanP S Kim
Jun 8, 2001·Annual Review of Biochemistry·D M Eckert, P S Kim
Apr 3, 2003·Nature Reviews. Molecular Cell Biology·Peter M Colman, Michael C Lawrence
Jul 3, 2004·The Journal of Antimicrobial Chemotherapy·Michael L Greenberg, Nick Cammack
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·John J DwyerMary K Delmedico
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Brett D WelchMichael S Kay
Feb 28, 2008·The Journal of Biological Chemistry·Yuxian HeLinqi Zhang
Apr 25, 2008·Journal of Virology·Dirk EgginkBen Berkhout
Dec 17, 2008·The Journal of Biological Chemistry·Kazuki IzumiMasao Matsuoka
Jun 3, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Huihui ChongYouchun Wang
Jul 21, 2009·The Journal of Biological Chemistry·Dirk EgginkRogier W Sanders
Dec 25, 2009·Current Pharmaceutical Design·Imke Steffen, Stefan Pöhlmann
Aug 20, 2010·Journal of Virology·Brett D WelchMichael S Kay
Oct 13, 2010·The Journal of Biological Chemistry·Kazuya ShimuraEiichi N Kodama
Dec 7, 2010·Current Pharmaceutical Design·Dirk EgginkRogier W Sanders
Apr 26, 2011·Antiviral Research·Ben Berkhout, Rogier W Sanders
Jul 19, 2011·Biochimica Et Biophysica Acta·Avraham AshkenaziYechiel Shai
May 1, 2010·Viruses·Michael A LobritzEric J Arts
Jan 10, 2012·The Journal of Biological Chemistry·Xue YaoYuxian He

❮ Previous
Next ❯

Citations

May 12, 2015·DNA and Cell Biology·Marco WeisshaarRichard K Plemper
Nov 22, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shan SuShibo Jiang
Jul 28, 2016·Organic & Biomolecular Chemistry·Guodong LiangKeliang Liu
Oct 12, 2018·Organic & Biomolecular Chemistry·Olapeju BolarinwaJianfeng Cai
Feb 27, 2016·AIDS·Huihui ChongYuxian He
Mar 15, 2018·Frontiers in Cellular and Infection Microbiology·Xiujuan ZhangYuxian He
May 19, 2019·Cellular and Molecular Life Sciences : CMLS·Liana Costa Pereira Vilas BoasOctávio Luiz Franco
Oct 13, 2020·Frontiers in Pharmacology·Arun Suria Karnan MahendranCheng Foh Le
May 7, 2021·Chemical Communications : Chem Comm·Guangyan ZhouMiriam Gochin
Oct 1, 2021·Journal of Computational Chemistry·Faiyaz Md EfazMohammad A Halim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.